Neurodevelopmental (ND) Follow-Up at Three Years Corrected Age (CA) of Extremely Preterm Infants Treated with Prophylactic Indomethacin in the First 24 Hours of Life for the Prevention of Patent Ductus Arteriosus (PDA)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.